Travere Therapeutics, Inc. TVTX
51.89 USD -0.15 (-0.29%)
Nov 12, 2026, 3:20 PM EST
51.11 Day range 52.52
22.59 52-week range 68.73
- YTD
- +35.80%
- 1 year
- +42.28%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 490.73M | 233.18M | 145.24M | 109.46M | 131.84M | |
| 480.39M | 225.43M | 133.79M | 105.04M | 128.02M | |
| -62.82M | -323.83M | -388.14M | -319.81M | -199.43M | |
| -25.55M | -321.55M | -111.40M | -278.48M | -180.09M | |
| -0.29 | -4.08 | -1.50 | -4.37 | -3.01 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 93.03M | 58.53M | 58.18M | 61.69M | 165.75M | |
| 605.19M | 594.13M | 788.91M | 672.59M | 776.63M | |
| 490.36M | 535.05M | 588.10M | 629.73M | 474.52M | |
| 328.73M | 401.58M | 404.78M | 407.49M | 261.99M | |
| 114.83M | 59.08M | 200.81M | 42.85M | 302.11M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 37.78M | -237.47M | -280.02M | -186.29M | -14.79M | |
| 27.89M | 99.33M | 55.78M | -32.55M | -137.62M | |
| -33.47M | 139.42M | 218.75M | 117.57M | 231.68M | |
| -58.16M | -36.21M | -41.59M | -28.37M | -24.15M | |
| 34.50M | 359.00K | -3.51M | -104.06M | 80.98M |